Hyperthermia (also called thermal therapy or thermotherapy) is a type of cancer treatment whereby body tissue is exposed to high temperatures (up to 113 degrees). Research has shown that high temperatures can damage and destroy cancer cells, usually causing minimal damage to normal tissues.  By destroying cancer cells and damaging proteins and structures within cells, hyperthermia can reduce tumors. 
Beneficial in cancer treatments
Hyperthermia is used most effectively in the context of comprehensive cancer therapies, which may even resort to radiotherapy and chemotherapy. [1, 3] Hyperthermia may increase the sensitivity of some cancer cells to radiation or damage other cancer cells that radiation cannot destroy. When hyperthermia is combined with radiation therapy, they are often administered one hour apart. Hyperthermia can also improve the effects of certain anti-cancer drugs.
Extensive clinical research has been conducted to study hyperthermia in combination with radiotherapy or chemotherapy. These studies have focused on the treatment of several types of cancer, including sarcoma, melanoma, and cancers of the head and neck, brain, lung, esophagus, breast, bladder, rectum, liver, appendix, cervix and the peritoneal lining, mesothelioma, and others (1, 3-7).
Many of these studies, although not all, have indicated a significant reduction in tumor size when hyperthermia is combined with other treatments. [1, 3, 6, 7] In view of all this, can you imagine what it can do in combination with nutritional, immunological approaches together with detoxification?
How is it done?
When local hyperthermia is used, heat is applied in a small area, such as a tumor, and various techniques are used to provide energy to increase the temperature in that area. Different energy sources can be used to apply heat, for example, microwave, radiofrequency, and ultrasound.
Depending on where the tumor is located, there are several methods for the use of local hyperthermia. External approaches are used to treat tumors that are on or just below the skin. External applicators are placed around or near the region to be treated, and energy is concentrated in the tumor to raise its temperature.
Safe and effective
Most normal tissues are not damaged during hyperthermia if the temperature stays below 111 degrees. However, due to regional differences in tissue characteristics, higher temperatures may be recorded at certain points. This can result in burns, blisters, discomfort, or pain. [1, 5, 7]
Infusion techniques can cause tissue inflammation, blood clots, bleeding, and other injuries to normal tissues in the area that was treated with perfusion; however, most of these side effects are temporary. This kind of risk is minimized when the therapy is applied by a well-trained health professional.
At Verita Life, local hyperthermia is just one protocol that forms part of its integrative cancer treatment program, with Chief Medical Director, Dr. Adem Günes, a world-renowned expert and researcher in this field.
1 Van der Zee J. Heating the patient: a promising approach? Annals of Oncology 2002; 13(8):1173–1184. [PubMed Abstract]
2 Hildebrandt B, Wust P, Ahlers O, et al. The cellular and molecular basis of hyperthermia. Critical Reviews in Oncology/Hematology 2002; 43(1):33–56. [PubMed Abstract]
3 Wust P, Hildebrandt B, Sreenivasa G, et al. Hyperthermia in combined treatment of cancer. The Lancet Oncology 2002; 3(8):487–497. [PubMed Abstract]
4 Alexander HR. Isolation perfusion. In: DeVita VT Jr., Hellman S, Rosenberg SA, editors. Cancer: Principles and Practice of Oncology. Vol. 1 and 2. 6th ed. Philadelphia: Lippincott Williams and Wilkins, 2001.
5 Falk MH, Issels RD. Hyperthermia in oncology. International Journal of Hyperthermia. 2001; 17(1):1–18. [PubMed Abstract]
6 Dewhirst MW, Gibbs FA Jr, Roemer RB, Samulski TV. Hyperthermia. In: Gunderson LL, Tepper JE, editors. Clinical Radiation Oncology. 1st ed. New York, NY: Churchill Livingstone, 2000.
7 Kapp DS, Hahn GM, Carlson RW. Principles of Hyperthermia. In: Bast RC Jr., Kufe DW, Pollock RE, et al., editors. Cancer Medicine e.5. 5th ed. Hamilton, Ontario: B.C. Decker Inc., 2000.